Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression of AML cell lines (HL60, KG1a, MOLM14 and U937) untreated or treated with metformin

ABSTRACT: We sought to obtain gene signature specific of high oxidative phsophorylation function.

ORGANISM(S): Homo sapiens

PROVIDER: GSE97346 | GEO | 2017/06/25

SECONDARY ACCESSION(S): PRJNA381479

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Expression data from melanoma cell lines

Project description:Differential gene expression analysis of parental and resistant sub-lines of melanoma cell lines treated or untreated with PLX4032 Using microarray we sought to obtain a genome-wide profile of differentially expressed genes in parental melanoma cell lines and resistant sub-lines in response to PLX4032 vs DMSO control treatment.

2010-11-26 | GSE24862 | GEO

Gene expression of MOLM14 (AML cell line) transfected with shCD39 or shCTRL

Project description:Relapses driven by chemoresistant leukemic cell populations are the main cause of mortality for patients with acute myeloid leukemia (AML). Here, we show that the ectonucleotidase CD39 (ENTPD1) is upregulated in cytarabine (AraC)-resistant leukemic cells from both AML cell lines and patient samples in vivo and in vitro. Similarly, CD39 cell surface expression and activity is increased in AML patients upon chemotherapy compared to diagnosis and enrichment in CD39-expressing blasts is a marker of adverse prognosis in the clinics. High CD39 activity promotes AraC resistance by enhancing mitochondrial activity and biogenesis through activation of a cAMP-mediated response. Finally, genetic and pharmacological inhibition of CD39 eATPase activity blocks the mitochondrial reprogramming triggered by AraC treatment and markedly enhances its cytotoxicity in AML cells in vitro and in vivo. Together, these results reveal CD39 as a new prognostic marker and a promising therapeutic target to improve chemotherapy response in AML.

2020-09-29 | GSE136551 | GEO

Gene expression of MOLM14 (AML cell line) transfected with siATF4 or siCTRL

Project description:Assessment of the impact of ATF4 silencing in FLT3-ITD/MLL AML cell lines

2021-05-24 | GSE151130 | GEO

29 untreated breast cancer cell lines vs. pool of all 29 cell lines

Project description: Not available

| S-ECPF-GEOD-51086 | biostudies-other

Effects of PMA on exon usage of HL60, THP-1, and U937 cells

Project description:Myeloid leukemia cell lines HL60, THP-1, and U937 undergo macrophage-like differentiation after treatment with phorbol ester. To explore genes whose exon usage was altered during macrophage differentiation, we compared exome of PMA-treated (differentated) and vehicle-treated (undifferentiated) myeloid cell lines.

2013-09-25 | GSE20567 | GEO

Cell lines LS180 vs U937

Project description:Dr. Esko's laboratory focuses on the structure, function, and biosynthesis of glycoproteins and proteoglycans. This laboratory also works on the design and synthesis of small molecule inhibitors of glycosylation.

2011-02-17 | GSE27351 | GEO

Hi-C detects novel rearrangements in HL60 and HL60/S4 cell lines

Project description:Hi-C detects novel rearrangements in HL60 and HL60/S4 cell lines

2018-12-02 | GSE120815 | GEO

Sodium orthovanadate inhibits growth of acute leukemia HL60 cells and HL60/A cells in vitro.

Project description: Not available

| S-EPMC7522360 | biostudies-literature

Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937.

Project description: Not available

| S-EPMC6933542 | biostudies-literature

Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores.

Project description: Not available